http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35810560

Outgoing Links

Predicate Object
contentType Journal Article
issn 2572-9241
issueIdentifier 6
pageRange e873-
publicationName HemaSphere
startingPage e873
bibliographicCitation Lambert J, Di Blasi R, Rabian F, Dourthe ME, Baruchel A, Thiéblemont C, Boissel N, Levy V, Picat MQ, Chevret S. Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data. Hemasphere. 2023 Jun;7(6):e873. PMID: 37260917; PMCID: PMC10228472.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ac58786edd4c8fa360dfd7d41471b79
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19b869fb2043dc5db339fc38a4324836
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4080fac74964d4174de5f45b490c488
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_044712a488653c6f152adc02caf8a1ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7053506d0e926fc576dccc20f4f509ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0b37182efeaef26540069bd20d8e42c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04075a60c9437adc302f1cf97148314a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f2182ca1d47be458734361ecce08570
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecfdb75eaba207cb87d8a831ae9f1c58
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f5c7f6826c9e83706f7496c20829340
date 202306
identifier https://doi.org/10.1097/hs9.0000000000000873
https://pubmed.ncbi.nlm.nih.gov/37260917
https://pubmed.ncbi.nlm.nih.gov/PMC10228472
isPartOf https://portal.issn.org/resource/ISSN/2572-9241
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/48447
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data

Showing number of triples: 1 to 27 of 27.